NantWorks Inks Licensing Deal With Amgen

Los Angeles-based NantPharma, one of the companies that is part of Patrick Soon-Shiong's NantWorks companies, said this morning that it has entered into a license agreement with Thousand Oaks-based Amgen. NantPharma said it has acquired exclusive rights to develop and commercialize worldwide, excluding Japan, Russia and certain other Central Asian countries, AMG 337, a compound Amgen hhas been developing for cancer therapy. Financial details of the deal were not disclosed. The license is the second between NantWorks and Amgen